Interesting WSJ article

http://online.wsj.com/article/SB1000142412788...74012.html

"This strategy may be inviting a hell of a battle with the health industry, where the incentives are rigged against startups and the empire usually finds a way of striking back. Witness the medical-practice regulations that make medicine a cartel against competitors."

Wouldn't be surprised to see some big pharma actually buy BMSN to shelve the technology should it work.